Innovative treatment for Hepatitis C virus


Hepatitis C virus (HCV) infection is a major public health challenge for Australia. Acute infection progresses to chronic disease in up to 75% of cases, and these people are at risk of progressive liver fibrosis leading to cirrhosis, liver failure and hepatocellular carcinoma (HCC). Around 20%–30% of people with chronic HCV infection will develop cirrhosis, generally after 20–30 years of infection. Continue reading